DOOD fluctuates 62.3% within 24 hours: High trading volume amplifies low liquidity volatility
Bitget Pulse2026/03/13 12:23Volatility Overview
Over the past 24 hours, the price of DOOD rebounded from a low of $0.002830 to a high of $0.004594, and is currently trading at $0.003786, with a fluctuation amplitude of 62.3%. The 24-hour trading volume is approximately $17.7 million, which is high compared to the market cap (about $22 million), indicating increased activity.
Analysis of the Reasons for the Abnormal Movement
- The 24-hour trading volume surged to $17.7 million, accompanied by active spot and futures trading, causing sharp price swings.
- There is no official announcement or mainstream news event directly triggering this; the Coinbase listing effect (February 5th) has faded, and the low-liquidity market is prone to speculative amplification.
Market View and Outlook
The mainstream market sentiment is bearish. The community is focused on the annual cumulative decline of more than 91% and thin liquidity (high trading volume/market cap ratio yet prone to slippage). Analysts warn of significant short-term volatility risk, with the market likely to continue its downward trend. Technical discussions on X show mixed signals, and it is advised to watch the support level near $0.0028.
Note: This analysis is automatically generated by AI based on public data and on-chain monitoring and is for informational reference only.Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Novo Nordisk (NVO.US) renamed to "Novo" for a fresh start—Can multi-line breakthroughs dispel the shadow over its stock price?
Danish pharmaceutical company Novo Nordisk (NVO.US) has launched a comprehensive rebranding centered around the shorter name "Novo." The company will use "Novo" in daily brand promotion, but its legal name will remain Novo Nordisk A/S.
High interest rates are not the "end" of US stocks? Is profitability the real key?
JPMorgan believes that profit growth is the key factor determining the resilience of U.S. stock valuations. Data since 1950 shows an "inverted U-shaped" relationship between the 10-year U.S. Treasury yield and S&P 500 valuations. Based on current profit levels, yields would need to reach about 5%-6% to significantly compress valuations. As long as profit growth remains above 15%, there is still room for valuations to be re-rated. If the yield curve steepens in a bear market, cyclical sectors such as energy and financials will benefit more; if it flattens, technology stocks will have a relative advantage.
The "Outlier" Investment Art in the New Era of Berky
Metaplanet to launch Hong Kong Bitcoin investment subsidiary with $1 million capital
Crypto prices
More
